PSC
9
6
6
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (9)
Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
PET/MRI of Primary Sclerosing Cholangitis
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
Colangioids to Define the Genetic Factors Involved in Atypical Primary Sclerosing Cholangitis
Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
Swiss Primary Sclerosing Cholangitis Cohort Study
A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups.
Value of MRCP+ And Liver Multiscan in the Management of Dominant Strictures in Primary Sclerosing Cholangitis
Quantitative Magnetic Resonance Imaging in Biliary Disease: Health Economics Study